Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis
暂无分享,去创建一个
[1] Elizabeth Fisher,et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains , 2007, Annals of neurology.
[2] Hompson,et al. A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .
[3] Marco Battaglini,et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.
[4] D. Louis Collins,et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion , 2007, NeuroImage.
[5] Nick C Fox,et al. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis , 2006, Journal of magnetic resonance imaging : JMRI.
[6] W. Klunk,et al. Imaging of CNS myelin by positron-emission tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[7] P M Matthews,et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.
[8] Frederik Barkhof,et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.
[9] Stephen G Waxman,et al. Na+ channel expression along axons in multiple sclerosis and its models. , 2004, Trends in pharmacological sciences.
[10] Gareth J. Barker,et al. Diffusion tensor imaging of post mortem multiple sclerosis brain , 2007, NeuroImage.
[11] P. Matthews,et al. Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.
[12] G. Buzsáki,et al. Inhibition and Brain Work , 2007, Neuron.
[13] Bruce D. Trapp,et al. Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.
[14] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[15] D. Arnold,et al. The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis , 2007, Multiple sclerosis.
[16] P. Basser,et al. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.
[17] Susumu Mori,et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. , 2007, Brain : a journal of neurology.
[18] P. V. van Zijl,et al. Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging , 1999, Annals of neurology.
[19] H. McFarland,et al. Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis , 2006, Neurology.
[20] R I Grossman,et al. Magnetization transfer in multiple sclerosis , 1994, Annals of neurology.
[21] Daniel Pelletier,et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.
[22] A. MacKay,et al. In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.
[23] Stephen Smith,et al. Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. , 2003, Brain : a journal of neurology.
[24] Nick C. Fox,et al. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.
[25] P. Matthews,et al. Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.
[26] J L Ostuni,et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis , 2001, Multiple sclerosis.
[27] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[28] J H Simon,et al. Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.
[29] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[30] P M Matthews,et al. Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. , 2002, Brain : a journal of neurology.
[31] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[32] H. Lassmann. Multiple sclerosis: Is there neurodegeneration independent from inflammation? , 2007, Journal of the Neurological Sciences.
[33] F. Condé,et al. Early N-Acetylaspartate Depletion Is a Marker of Neuronal Dysfunction in Rats and Primates Chronically Treated with the Mitochondrial Toxin 3-Nitropropionic Acid , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] P M Matthews,et al. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.
[35] My-Van Au Duong,et al. Functional magnetic resonance imaging and cognition at the very early stage of MS , 2006, Journal of the Neurological Sciences.
[36] P M Matthews,et al. Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation. , 2004, Restorative neurology and neuroscience.
[37] P. Narayana,et al. Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging , 2007, American Journal of Neuroradiology.
[38] C. Laule,et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.
[39] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[40] Frederik Barkhof,et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.
[41] R I Grossman,et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.
[42] H. Schild,et al. Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy , 2007, American Journal of Neuroradiology.
[43] E. Radue,et al. Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a , 2005, Neurology.
[44] P M Matthews,et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis , 2000, Annals of neurology.
[45] Frederik Barkhof,et al. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. , 2007, Archives of neurology.
[46] R. Henkelman,et al. Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.
[47] Hans Lassmann,et al. Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.
[48] David H. Miller,et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain , 2007, Journal of magnetic resonance imaging : JMRI.
[49] Dieter Vaitl,et al. Distinct mechanisms of altered brain activation in patients with multiple sclerosis , 2007, NeuroImage.
[50] Nick C Fox,et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[51] Nick C. Fox,et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.
[52] V. M. Anderson BSc,et al. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: Sample size estimates , 2007, Journal of Neurology.
[53] J. Moffett,et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.
[54] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.